Search research articles
Contact Us
Filters
Showing results (71-80 of 130) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Rituximab dose-escalation trial in chronic lymphocytic leukemia
S M O'Brien, H Kantarjian, D A Thomas, et al.
British Journal of Haematology
|
May 18, 2006
Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemia
W Ma, I Jilani, M Gorre, et al.
Leukemia
|
January 7, 2012
Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies
F J Giles, N Vey, D Rizzieri, et al.
Oncogene
|
October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma
K R Kelly, C M Espitia, D Mahalingam, et al.
Annals of Internal Medicine
|
October 1, 1996
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia
M W Kattan, Y Inoue, F J Giles, et al.
Leukemia
|
August 2, 2001
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome
S Verstovsek, H Kantarjian, E Estey, et al.
Cancer Treatment Reviews
|
March 11, 2017
Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis
R Costa, N Gill, A W Rademaker, et al.
Cancer
|
December 24, 1997
Comparison of Technetium-99m sestamibi and indium-111 octreotide imaging in a patient with Ewing's sarcoma before and after stem cell transplantation
F J Giles, A D Waxman, K N Nguyen, et al.
Blood
|
December 12, 2001
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
E H Estey, P F Thall, J E Cortes, et al.
Leukemia & Lymphoma
|
February 1, 1996
Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation
R M Look, S W Lim, A D Waxman, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 130) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Rituximab dose-escalation trial in chronic lymphocytic leukemia
S M O'Brien, H Kantarjian, D A Thomas, et al.
British Journal of Haematology
|
May 18, 2006
Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemia
W Ma, I Jilani, M Gorre, et al.
Leukemia
|
January 7, 2012
Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies
F J Giles, N Vey, D Rizzieri, et al.
Oncogene
|
October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma
K R Kelly, C M Espitia, D Mahalingam, et al.
Annals of Internal Medicine
|
October 1, 1996
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia
M W Kattan, Y Inoue, F J Giles, et al.
Leukemia
|
August 2, 2001
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome
S Verstovsek, H Kantarjian, E Estey, et al.
Cancer Treatment Reviews
|
March 11, 2017
Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis
R Costa, N Gill, A W Rademaker, et al.
Cancer
|
December 24, 1997
Comparison of Technetium-99m sestamibi and indium-111 octreotide imaging in a patient with Ewing's sarcoma before and after stem cell transplantation
F J Giles, A D Waxman, K N Nguyen, et al.
Blood
|
December 12, 2001
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
E H Estey, P F Thall, J E Cortes, et al.
Leukemia & Lymphoma
|
February 1, 1996
Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation
R M Look, S W Lim, A D Waxman, et al.
Page
of 13